MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3779/j.issn.1009-3419.2012.01.02

Медицинская библиотека · Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2012

[Evaluation of efficacy and safety of bevacizumab combined with chemotherapy for Chinese patients with advanced non-small cell lung cancer].

Zhao Xiao, Wang Mengzhao, Zhang Li, Li Longyun, Zhong Wei

Клиническое исследование IV фазыАннотация на английскомСтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

BACKGROUND AND

OBJECTIVE

The current study reported the result of bevacizumab treatment administered to 25 Chinese patients with advanced non-small cell lung cancer (NSCLC) who were treated at the Peking Union Medical College Hospital as a part of the SAiL (MO19390) trial. This trial is an open, international multicenter, single-arm clinical study that assesses the safety and efficacy of first-line bevacizumab-based therapy in advanced NSCLC.

METHODS

Twenty-five Chinese patients with advanced non-squamous NSCLC received bevacizumab (15 mg/kg) combined with chemotherapy (carboplatin plus paclitaxel) treatment from August 2007 to February 2008. Adverse effects (AEs), objective response rate (ORR), median time to progression (TTP), and overall survival (OS) were measured.

RESULTS

AEs were generally mild and reversible. The most frequent AEs were alopecia, peripheral neuropathy, rash, proteinuria, nausea/vomitting, fatigue, myalgia, bleeding, and hypertension. The partial remission and stable disease rates were 68% and 28%, respectively. The median TTP and OS of all patients were 11.2 and 19.3 months, respectively.

CONCLUSION

Bevacizumab combined with carboplatin-based chemotherapy may be well tolerated and beneficial for Chinese patients with non-squamous NSCLC.

Для цитирования: Zhao Xiao, Wang Mengzhao, Zhang Li, Li Longyun, Zhong Wei. [Evaluation of efficacy and safety of bevacizumab combined with chemotherapy for Chinese patients with advanced non-small cell lung cancer].. Zhongguo fei ai za zhi = Chinese journal of lung cancer. 2012. DOI: 10.3779/j.issn.1009-3419.2012.01.02.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.